Dacarbazine, 97.5%, an antineoplastic agent

Name: Dacarbazine, 97.5%, an antineoplastic agent | 4342-03-4
Brand: J&K Chemical
SKU: JK308447_1_G
Price: 95.0 USD
Availability: InStock

Cat. No JK308447_1_G

Vendor: J&K Chemical

Product Information

Product Name

Dacarbazine, 97.5%, an antineoplastic agent

Brand Name

J&K

Product Number

308447

CAS

4342-03-4

Molecular Formula

C6H10N6O

Molecular Weight

182.18

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

135398738

IUPAC Name

4-(E)-dimethylaminodiazenyl-1H-imidazole-5-carboxamide

InChI Key

FDKXTQMXEQVLRF-ZHACJKMWSA-N

SMILES

CN(C)/N=N/C1=C(NC=N1)C(=O)N

Safety Information

GHS Symbols

Signal Word

Danger

Hazard Statement

H302

H312

H332

H315

H319

H335

H340

H350

Precautionary Statement

P270

P330

P501

P280

P321

P261

P271

P319

P405

P203

P318

P301+P317

P302+P352

P362+P364

P304+P340

P332+P317

P264+P265

P305+P351+P338

P337+P317

P403+P233

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

Zerumbone Induces Apoptosis and Inhibits Migration of A2058 Melanoma stem-like Cells by Producing Reactive Oxygen Species, Causing G2/M Cell Cycle Arrest, and Controlling the Expression of Genes Linked to Metastasis

Publication Name: Indian journal of clinical biochemistry : IJCB

Publication Date: 2026-06

DOI: 10.1007/s12291-024-01260-6

[Sarcomas : Clinical introduction]

Publication Name: Radiologie (Heidelberg, Germany)

Publication Date: 2026-05

DOI: 10.1007/s00117-026-01581-y

Correction: What’s in a name? Metabolite identification: challenges and pitfalls in untargeted metabolomics

Publication Name: Metabolomics : Official journal of the Metabolomic Society

Publication Date: 2026-03-26

DOI: 10.1007/s11306-025-02387-0|10.1007/s11306-026-02418-4

Isoxazole derivatives as multi-target agents: virucidal, antibacterial, and antiproliferative effects on skin cancer cells

Publication Name: Pharmacological reports : PR

Publication Date: 2026-03-04

DOI: 10.1007/s43440-026-00839-5

Resolution of vanishing bile duct syndrome in a patient associated with refractory hodgkin lymphoma following Anti–PD-1 therapy: a case report and literature review

Publication Name: Annals of Hematology

Publication Date: 2026-02-26

DOI: 10.1007/s00277-026-06745-3

Dacarbazine, 97.5%, an antineoplastic agent

Product Information

General Information

Safety Information

References Data Source From Pubchem

Zerumbone Induces Apoptosis and Inhibits Migration of A2058 Melanoma stem-like Cells by Producing Reactive Oxygen Species, Causing G2/M Cell Cycle Arrest, and Controlling the Expression of Genes Linked to Metastasis

[Sarcomas : Clinical introduction]

Correction: What’s in a name? Metabolite identification: challenges and pitfalls in untargeted metabolomics

Isoxazole derivatives as multi-target agents: virucidal, antibacterial, and antiproliferative effects on skin cancer cells

Resolution of vanishing bile duct syndrome in a patient associated with refractory hodgkin lymphoma following Anti–PD-1 therapy: a case report and literature review